ArticleJournal of personalized medicine2021

SLCO1B1 Phenotype and CYP3A5 Polymorphism Significantly Affect Atorvastatin Bioavailability.

Pablo Zubiaur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.